Truist raises Quest Diagnostics stock price target on strong results
Covered in this story
What has happened since
- Quest Diagnostics is up 3.4% since this was published, 88 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Truist Securities’s $250 target on $DGX is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.
Truist Securities’s track record →Call it yourself
No member calls on $DGX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Quest Diagnostics →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.